Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Assets Average (2016 - 2025)

Ptc Therapeutics has reported Assets Average over the past 13 years, most recently at $2.8 billion for Q4 2025.

  • Quarterly results put Assets Average at $2.8 billion for Q4 2025, up 56.25% from a year ago — trailing twelve months through Dec 2025 was $2.8 billion (up 56.25% YoY), and the annual figure for FY2025 was $2.3 billion, up 27.86%.
  • Assets Average for Q4 2025 was $2.8 billion at Ptc Therapeutics, up from $2.6 billion in the prior quarter.
  • Over the last five years, Assets Average for PTCT hit a ceiling of $2.8 billion in Q4 2025 and a floor of $1.3 billion in Q3 2023.
  • Median Assets Average over the past 5 years was $1.9 billion (2022), compared with a mean of $1.9 billion.
  • Biggest five-year swings in Assets Average: fell 23.15% in 2023 and later soared 56.25% in 2025.
  • Ptc Therapeutics' Assets Average stood at $2.0 billion in 2021, then decreased by 16.81% to $1.6 billion in 2022, then decreased by 3.85% to $1.6 billion in 2023, then grew by 12.41% to $1.8 billion in 2024, then soared by 56.25% to $2.8 billion in 2025.
  • The last three reported values for Assets Average were $2.8 billion (Q4 2025), $2.6 billion (Q3 2025), and $2.6 billion (Q2 2025) per Business Quant data.